SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007002
Filing Date
2023-03-09
Accepted
2023-03-09 16:03:52
Documents
14
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20230309.htm   iXBRL 8-K 69396
2 EX-99.1 life-ex99_1.htm EX-99 233094
3 GRAPHIC img140509417_0.jpg GRAPHIC 10984
  Complete submission text file 0000950170-23-007002.txt   450800

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230309.xsd EX-101.SCH 2470
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230309_pre.xml EX-101.PRE 10992
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230309_lab.xml EX-101.LAB 13352
8 EXTRACTED XBRL INSTANCE DOCUMENT life-20230309_htm.xml XML 4708
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 23719690
SIC: 2836 Biological Products, (No Diagnostic Substances)